Skip to content
healthcare.dev
Get a free key

QINLOCK

NDC 73207-101, Ripretinib, tablet, from Deciphera Pharmaceuticals, LLC.

Product NDC
73207-101
Status
Listed
Labeler
Deciphera Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213973
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73207-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIPRETINIB50 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]; Stem Cell Factor (KIT) Receptor Inhibitors [MoA]

Package NDCNDC-11Package
73207-101-30732070101301 BOTTLE in 1 CARTON (73207-101-30) / 90 TABLET in 1 BOTTLE
73207-101-31732070101311 BOTTLE in 1 CARTON (73207-101-31) / 30 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9f18e462-03dd-4296-a02a-a0577e3ee78d

Use it

Look up 73207-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73207-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73207-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.